Literature DB >> 25737034

Comparison of HbA1c, blood pressure, and cholesterol (ABC) control in type 2 diabetes attending general medical clinics and specialist diabetes clinics in Thailand.

Sokha Sieng1, Bandit Thinkamrop2, Wongsa Laohasiriwong2, Cameron Hurst3.   

Abstract

AIMS: The aim of this study was to compare the achievement of clinical targets for patients with type 2 diabetes mellitus (T2DM) in general medical clinics (GMCs) and specialist diabetes clinics (SDCs) for different hospital types (regional, provincial and community) in Thailand.
METHODS: We used the medical records of patients (n=26,860) with T2DM from 595 hospitals (26 regional, 70 provincial and 499 community) across all 77 provinces in Thailand. Generalized linear mixed models were used to conduct multi-level modeling to evaluate the achievement of individual outcomes (A - glycated hemoglobin (HbA1c) <7.0% (53 mmol/mol), B - Blood Pressure (BP) <140/80 mmHg and C - LDL-Cholesterol <100mg/dL) and aggregated outcomes (AllABC - achieved all three of the targets, AnyABC - achieved at least one target, ABCcount - the number of targets achieved: 0, 1, 2 or 3).
RESULTS: Neither clinic types (SDCs or GMCs) were consistency superior across all hospital types. For regional hospitals, SDCs were associated with higher odds of achieving BP, AnyABC, and ABCcount (OR=1.55, 95%CI: 1.25-1.92, p<0.001; OR=1.35, 95%CI: 1.02-1.79; p=0.04; RR=1.10, 95%CI: 1.01-1.20, p=0.03, respectively). For provincial hospitals, SDCs exhibited higher achievement of BP and LDL-C (OR=1.52, 95%CI: 1.23-1.87, p<0.001; OR=1.28, 95%CI: 1.04-1.58, p=0.02, respectively). For community hospitals, however GMCs demonstrated higher achievement of BP and AnyABC (OR=0.81, 95%CI: 0.67-0.98, p=0.03; OR=0.74, 95%CI: 0.56-0.97, p=0.03, respectively).
CONCLUSIONS: In larger (regional and provincial) hospitals, SDCs outperform GMCs in several (but not all) clinical targets. In contrast, in community hospital, where most patients with T2DM are serviced, GMCs were shown to have superior performance.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ABC goals; General medical clinics; Specialist diabetes clinics; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25737034     DOI: 10.1016/j.diabres.2015.02.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan.

Authors:  Bhagwan Das; Aisha Sheikh; Bilal Ahmed; Najmul Islam
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

2.  Psychometric properties of the general self-efficacy scale among Thais with type 2 diabetes: a multicenter study.

Authors:  Cameron Hurst; Nitchamon Rakkapao; Eva Malacova; Sirima Mongkolsomlit; Pear Pongsachareonnont; Ram Rangsin; Yindee Promsiripaiboon; Gunter Hartel
Journal:  PeerJ       Date:  2022-05-23       Impact factor: 3.061

3.  The impact of the quality of care and other factors on progression of chronic kidney disease in Thai patients with Type 2 Diabetes Mellitus: A nationwide cohort study.

Authors:  Paithoon Sonthon; Supannee Promthet; Siribha Changsirikulchai; Ram Rangsin; Bandit Thinkhamrop; Suthee Rattanamongkolgul; Cameron P Hurst
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

4.  A combination of process of care and clinical target among type 2 diabetes mellitus patients in general medical clinics and specialist diabetes clinics at hospital levels.

Authors:  Sokha Sieng; Cameron Hurst
Journal:  BMC Health Serv Res       Date:  2017-08-07       Impact factor: 2.655

5.  Impact of diabetes self-management, diabetes management self-efficacy and diabetes knowledge on glycemic control in people with Type 2 Diabetes (T2D): A multi-center study in Thailand.

Authors:  Cameron P Hurst; Nitchamon Rakkapao; Karen Hay
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

6.  Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center.

Authors:  Yotsapon Thewjitcharoen; Nalin Yenseung; Areeya Malidaeng; Soontaree Nakasatien; Phawinpon Chotwanvirat; Sirinate Krittiyawong; Ekgaluck Wanothayaroj; Thep Himathongkam
Journal:  Diabetol Metab Syndr       Date:  2017-12-01       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.